MFP
WST icon

Meramec Financial Planners’s West Pharmaceutical WST Stock Holding History

Meramec Financial Planners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Sell
50
-40
-44% -$12.2K 0.01% 318
2026
Q1 		$25K Sell
90
-6
-6% -$1.49K 0.01% 264
2025
Q4 		$23.9K Buy
+96
New +$26.3K 0.01% 266

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Meramec Financial Planners's WST Position: Q2 2026 in Review

Meramec Financial Planners reduced its West Pharmaceutical (WST) stake by 44% in Q2 2026, selling an estimated $12.2K and leaving 50 shares worth $16.6K. The position accounts for 0.01% of the portfolio, ranked #318.

Meramec Financial Planners first reported a position in WST in Q4 2025 and has held it in 3 quarters since. The position peaked at $25K in Q1 2026. 829 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Meramec Financial Planners held 50 shares of West Pharmaceutical worth $16.6K as of Q2 2026.
  • Meramec Financial Planners sold 40 West Pharmaceutical shares in Q2 2026, an estimated $12.2K.
  • West Pharmaceutical made up 0.01% of Meramec Financial Planners's portfolio in Q2 2026, its #318 holding.
  • Meramec Financial Planners first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Meramec Financial Planners's West Pharmaceutical position peaked at $25K in Q1 2026.
  • 829 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.